Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
$0.60
-1.8%
$0.60
$0.32
$0.65
$174.31M0.237,300 shs1,000 shs
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$0.92
-3.3%
$1.06
$0.48
$1.66
$52.79M0.33470,237 shs330,234 shs
Isoray, Inc. stock logo
ISR
Isoray
$0.37
$0.19
$0.45
$54.57M1.48290,697 shs145,000 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.60
-2.7%
$4.68
$4.01
$9.33
$77.79M1.32194,343 shs72,522 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
-1.81%-6.34%-2.38%+16.28%+62.79%
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-3.27%-2.39%-13.20%-22.03%+25.08%
Isoray, Inc. stock logo
ISR
Isoray
0.00%0.00%0.00%0.00%0.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-2.75%-4.56%-1.92%-5.74%-12.05%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
0.6118 of 5 stars
0.05.00.00.02.00.00.0
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
2.3062 of 5 stars
3.85.00.00.00.00.00.6
Isoray, Inc. stock logo
ISR
Isoray
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.4441 of 5 stars
3.62.00.00.01.70.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
0.00
N/AN/AN/A
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
3.50
Strong Buy$2.50171.71% Upside
Isoray, Inc. stock logo
ISR
Isoray
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67153.62% Upside

Current Analyst Ratings Breakdown

Latest EDTXF, ICCM, ISR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/29/2025
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$2.50
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/28/2025
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$2.50 ➝ $2.50
(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
$1.67M102.48N/AN/A($0.07) per share-8.56
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$3.29M15.52N/AN/A$0.12 per share7.67
Isoray, Inc. stock logo
ISR
Isoray
$10.80M0.00N/AN/A$0.43 per share0.00
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.81$0.42 per share10.95$3.41 per share1.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
-$11.24M-$0.07N/AN/A-1,078.10%N/A-336.97%8/7/2025 (Estimated)
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$15.32M-$0.28N/AN/AN/A-467.37%-182.26%-112.65%8/19/2025 (Estimated)
Isoray, Inc. stock logo
ISR
Isoray
-$7.27M-$0.07N/AN/AN/A-115.91%-17.12%-16.15%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1046.0020.00N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest EDTXF, ICCM, ISR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2025Q1 2025
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$0.08-$0.06+$0.02-$0.06$0.75 million$0.73 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/9/2025Q1 2025
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
N/A-$0.03N/A-$0.03N/A$0.40 million
3/27/2025Q4 2024
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$0.07-$0.08-$0.01-$0.08$1.07 million$1.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
N/AN/AN/AN/AN/A
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
N/AN/AN/AN/AN/A
Isoray, Inc. stock logo
ISR
Isoray
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
N/A
0.09
0.08
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
0.02
1.89
1.48
Isoray, Inc. stock logo
ISR
Isoray
N/A
14.38
13.99
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
N/A
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
0.62%
Isoray, Inc. stock logo
ISR
Isoray
11.32%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
1.50%
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
2.44%
Isoray, Inc. stock logo
ISR
Isoray
2.42%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
29285.52 million281.24 millionNot Optionable
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
6055.50 million54.15 millionNot Optionable
Isoray, Inc. stock logo
ISR
Isoray
N/A142.11 million138.67 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Spectral Diagnostics stock logo

Spectral Diagnostics OTCMKTS:EDTXF

$0.60 -0.01 (-1.82%)
As of 06/23/2025 12:16 PM Eastern

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

IceCure Medical stock logo

IceCure Medical NASDAQ:ICCM

$0.92 -0.03 (-3.27%)
Closing price 06/23/2025 03:59 PM Eastern
Extended Trading
$0.96 +0.04 (+4.45%)
As of 06/23/2025 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Isoray stock logo

Isoray NYSE:ISR

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.60 -0.13 (-2.75%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$4.62 +0.02 (+0.33%)
As of 06/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.